Interplay between the gastric bacterial microbiota and Candida albicans during postantibiotic recolonization and gastritis

Infection and Immunity

Volumn 80, Issue 1, 2012, Pages 150-158

  Mason, Katie L ^a   Downward, John R Erb ^a   Falkowski, Nicole R ^a   Young, Vincent B ^a   Kao, John Y ^a   Huffnagle, Gary B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOPERAZONE; ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOSIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; CANDIDA ALBICANS; ENTEROCOCCUS; FEMALE; FUNGAL COLONIZATION; FUNGAL STRAIN; GASTRITIS; HISTOPATHOLOGY; LACTOBACILLUS; MICROBIAL COMMUNITY; MICROBIOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BACTERIUM; C57BL MOUSE; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; PATHOGENICITY; STOMACH; TIME;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOSIS; BACTERIA; CANDIDA ALBICANS; CEFOPERAZONE; FEMALE; GASTRITIS; MICE; MICE, INBRED C57BL; STOMACH; TIME FACTORS;

EID: 84857079839     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05162-11     Document Type: Article

References (50)

1. Antonopoulos DA, et al. 2009. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect. Immun. 77:2367-2375.
2. Artwohl J, McClain A, Cera L. 1988. Population changes of indigenous murine Candida pintolopesii under various experimental conditions and routes of inoculation. Appl. Environ. Microbiol. 54:2371-2372.
3. Balish E, Balish MJ, Salkowski CA, Lee KW, Bartizal KF. 1984. Colonization of congenitally athymic, gnotobiotic mice by Candida albicans. Appl. Environ. Microbiol. 47:647- 652.
4. Balish E, Jensen J, Warner T, Brekke J, Leonard B. 1993. Mucosal and disseminated candidiasis in gnotobiotic SCID mice. J. Med. Vet. Mycol. 31:143-154.
5. Bistoni F, et al. 1993. Mucosal and systemic T helper cell function after intragastric colonization of adult mice with Candida albicans. J. Infect. Dis. 168:1449 -1457.
6. Bonten MJ, Gaillard CA, van Tiel FH, van der Geest S, Stobberingh EE. 1995. Colonization and infection with Enterococcus faecalis in intensive care units: the role of antimicrobial agents. Antimicrob. Agents Chemother. 39:2783-2786.
7. Bonten MJ, et al. 1996. Epidemiology of colonization of patients and environment with vancomycin-resistant enterococci. Lancet 348:1615-1619.
8. Borges MC, Colares JK, Lima DM, Fonseca BA. 2009. Advantages and pitfalls of the polymerase chain reaction in the diagnosis of esophageal ulcers in AIDS patients. Dig Dis. Sci. 54:1933-1939.
9. Bozza S, et al. 2005. A crucial role for tryptophan catabolism at the host/Candida albicans interface. J. Immunol. 174:2910 -2918.
10. Brown JF, Balish E. 1978. Gastrointestinal microecology of BALB/c nude mice. Appl. Environ. Microbiol. 36:144 -159.
11. Cenci E, et al. 1995. T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J. Infect. Dis. 171:1279 -1288.
12. DiFebo G, Carnevale G, Sterrantino SF. 1985. Treatment of a case of advanced periodontitis: clinical procedures utilizing the "combined preparation" technique. Int. J. Periodontics Restorative Dent. 5:52- 62.
13. Franz CM, Holzapfel WH, Stiles ME. 1999. Enterococci at the crossroads of food safety? Int. J. Food Microbiol. 47:1-24.
14. Gotlieb-Jensen K, Andersen J. 1983. Occurrence of Candida in gastric ulcers: significance for the healing process. Gastroenterology 85:535-537.
15. Hasosah MY, Showail M, Al-Sahafi A, Satti M, Jacobson K. 2009. Esophageal candidiasis in an immunocompetent girl. World J. Pediatr. 5:152-154.
16. Helstrom PB, Balish E. 1979. Effect of oral tetracycline, the microbial flora, and the athymic state on gastrointestinal colonization and infection of BALB/c mice with Candida albicans. Infect. Immun. 23:764 -774.
17. Hummel RP, Oestreicher EJ, Maley MP, Macmillan BG. 1973. Inhibition of Candida albicans by Escherichia coli in vitro and in the germfree mouse. J. Surg. Res. 15:53-58.
18. Jacobus NV, Tally FP, Barza M, Gorbach SL. 1980. Susceptibility of anaerobic bacteria to cefoperazone and other beta-lactam antibiotics. Clin. Ther. 3:34 -38.
19. Karczewska E, et al. 2009. Assessment of coexistence of Helicobacter pylori and Candida fungi in diseases of the upper gastrointestinal tract. J. Physiol. Pharmacol. 60(Suppl 6):33-39.
20. Kennedy MJ. 1981. Inhibition of Candida albicans by the anaerobic oral flora of mice in vitro. Sabouraudia 19:205-208.
21. Kennedy MJ, Volz PA. 1983. Dissemination of yeasts after gastrointestinal inoculation in antibiotic-treated mice. Sabouraudia 21:27-33.
22. Kennedy MJ, Volz PA. 1985. Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism. Infect. Immun. 49:654-663.
23. Kennedy MJ, Volz PA. 1985. Effect of various antibiotics on gastrointestinal colonization and dissemination by Candida albicans. Sabouraudia 23:265-273.
24. Kinsman OS, Pitblado K. 1989. Candida albicans gastrointestinal colonization and invasion in the mouse: effect of antibacterial dosing, antifungal therapy and immunosuppression. Mycoses 32:664-674.
25. Kuehl CJ, Wood HD, Marsh TL, Schmidt TM, Young VB. 2005. Colonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiota. Infect. Immun. 73:6952- 6961.
26. Minoli G, et al. 1984. A prospective study of relationships between benign gastric ulcer, Candida, and medical treatment. Am. J. Gastroenterol. 79:95-97.
27. Moeseneder MM, Arrieta JM, Muyzer G, Winter C, Herndl GJ. 1999. Optimization of terminal-restriction fragment length polymorphism analysis for complex marine bacterioplankton communities and comparison with denaturing gradient gel electrophoresis. Appl. Environ. Microbiol. 65:3518 -3525.
28. Naglik JR, Fidel PR Jr, Odds FC. 2008. Animals models of mucosal Candida infection. FEMS Microbiol. Lett. 283:129 -139.
29. Nakajo K, et al. 2006. Resistance to acidic and alkaline environments in the endodontic pathogen Enterococcus faecalis. Oral Microbiol. Immunol. 21:283-288.
30. Noverr MC, Falkowski NR, McDonald RA, McKenzie AN, Huffnagle GB. 2005. Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect. Immun. 73:30 -38.
31. Noverr MC, Huffnagle GB. 2004. Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect. Immun. 72:6206-6210.
32. Noverr MC, Noggle RM, Toews GB, Huffnagle GB. 2004. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect. Immun. 72:4996 -5003.
33. Paster BJ, et al. 2001. Bacterial diversity in human subgingival plaque. J. Bacteriol. 183:3770 -3783.
34. Phillips AW, Balish E. 1966. Growth and invasiveness of Candida albicans in the germ-free and conventional mouse after oral challenge. Appl. Microbiol. 14:737-741.
35. Sabria-Leal M, et al. 1994. Molecular epidemiology of gastric colonization by Enterococcus faecalis in a surgical intensive care unit. Diagn. Microbiol. Infect. Dis. 19:197-202.
36. Samonis G, Anaissie EJ, Bodey GP. 1990. Effects of broad-spectrum antimicrobial agents on yeast colonization of the gastrointestinal tracts of mice. Antimicrob. Agents Chemother. 34:2420 -2422.
37. Savage DC. 1969. Microbial interference between indigenous yeast and lactobacilli in the rodent stomach. J. Bacteriol. 98:1278 -1283.
38. Savage DC, Dubos RJ. 1967. Localization of indigenous yeast in the murine stomach. J. Bacteriol. 94:1811-1816.
39. Schofield DA, Westwater C, Balish E. 2005. Divergent chemokine, cytokine and beta-defensin responses to gastric candidiasis in immunocompetent C57BL/6 and BALB/c mice. J. Med. Microbiol. 54:87-92.
40. Shimizu K, et al. 2011. Altered gut flora are associated with septic complications and death in critically ill patients with systemic inflammatory response syndrome. Dig Dis. Sci. 56:1171-1177.
41. van der Waaij D. 1987. Colonization resistance of the digestive tract: mechanism and clinical consequences. Nahrung 31:507-517.
42. van der Waaij D, Berghuis JM. 1974. Determination of the colonization resistance of the digestive tract of individual mice. J. Hyg. (Lond.) 72:379-387.
43. Van der Waaij D, Van der Waaij BD. 1990. The colonization resistance of the digestive tract in different animal species and in man; a comparative study. Epidemiol. Infect. 105:237-243.
44. van Ogtrop ML, Guiot HF, Mattie H, van Furth R. 1991. Modulation of the intestinal flora of mice by parenteral treatment with broad-spectrum cephalosporins. Antimicrob. Agents Chemother. 35:976 -982.
45. Wagner RD, Dohnalek M, Hilty M, Vezquez-Torres A, Balish E. 2000. Effects of probiotic bacteria on humoral immunity to Candida albicans in immunodeficient bg/bg-nu/nu and bg/bg-nul/+ mice. Rev. Iberoam. Micol. 17:55-59.
46. Wagner RD, et al. 1997. Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice. Infect. Immun. 65:4165- 4172.
47. Wagner RD, et al. 2000. Probiotic effects of feeding heat-killed Lactobacillus acidophilus and Lactobacillus casei to Candida albicans-colonized immunodeficient mice. J. Food Prot. 63:638-644.
48. Yamaguchi N, et al. 2005. Gastric colonization of Candida albicans differs in mice fed commercial and purified diets. J. Nutr. 135:109 -115.
49. Yamaguchi N, et al. 2006. Gastrointestinal Candida colonization promotes sensitization against food antigens by affecting the mucosal barrier in mice. Gut 55:954 -960.
50. Zwolinska-Wcislo M, Budak A, Trojanowska D, Bogdal J, Stachura J. 1998. Fungal colonization of the stomach and its clinical relevance. Mycoses 41:327-334.